Investors NYSE AMERICAN: LCTX Data Provided by Refinitiv. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases January 04, 2022 Lineage Cell Therapeutics to Present at H.C. Wainwright Bioconnect Virtual Conference December 20, 2021 Lineage Establishes Exclusive Worldwide Collaboration With Genentech for the Development and Commercialization of OpRegen® RPE Cell Therapy for the Treatment of Ocular Disorders November 30, 2021 Lineage Reports Fourth Case of Retinal Tissue Restoration With OpRegen® VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics at H.C. Wainwright Bioconnect Virtual Conference Jan 10, 2022 at 7:00 AM EST Lineage Cell Therapeutics, Inc. Conference Call to Discuss Worldwide OpRegen Collaboration Dec 20, 2021 at 8:00 AM EST Third Quarter 2021 Financial Results Earnings Call Nov 10, 2021 at 4:30 PM EST VIEW EVENTS & PRESENTATIONS
January 04, 2022 Lineage Cell Therapeutics to Present at H.C. Wainwright Bioconnect Virtual Conference
December 20, 2021 Lineage Establishes Exclusive Worldwide Collaboration With Genentech for the Development and Commercialization of OpRegen® RPE Cell Therapy for the Treatment of Ocular Disorders
Lineage Cell Therapeutics at H.C. Wainwright Bioconnect Virtual Conference Jan 10, 2022 at 7:00 AM EST
Lineage Cell Therapeutics, Inc. Conference Call to Discuss Worldwide OpRegen Collaboration Dec 20, 2021 at 8:00 AM EST
